Fast-track approval for ovarian cancer drug
Monday, December 19, 2016 - 16:02
in Health & Medicine
HealthDay News The anti-cancer drug Rubraca has been granted accelerated approval by the U.S. Food and Drug Administration to treat advanced ovarian cancer.